Patents Assigned to Pharmacon Forschung und Beratung GmbH
  • Publication number: 20090208558
    Abstract: The invention relates to the use of an antimycotic agent and an epithelial cell or endothelial cell adhesion inhibitor for producing a combination drug for the topical treatment of Candida mycoses selected from vulvovaginal candidiasis, oropharyngeal candidiasis (oral thrush), diaper dermatitis (diaper thrush) and intertriginous (Candida) eczema.
    Type: Application
    Filed: May 10, 2007
    Publication date: August 20, 2009
    Applicant: PHARMACON-FORSCHUNG UND BERATUNG GMBH
    Inventors: Christian Noe, Marion Noe
  • Publication number: 20080249119
    Abstract: The invention relates to homogemcitabines of general formula (2), with the meanings for the substituents as given in claim 1, method for production thereof, use for the production of the active agent gemcitabin and the use thereof for the production of medicaments for the treatment of proliferative diseases. The invention further relates to novel intermediates, as used in the inventive method.
    Type: Application
    Filed: July 20, 2006
    Publication date: October 9, 2008
    Applicant: PHARMACON-FORSCHUNG UND BERATUNG GMBH
    Inventors: Christian R. Noe, Muhamed Jasic, Hermann Kollmann, Karmin Saadat
  • Patent number: 5929253
    Abstract: L-aspartyl-L-thienylalanine methyl esters of the formula ##STR1## where A is a radical of the formula ##STR2## in which R can be H or CH.sub.3, a process for its preparation, and its use as sweetener.
    Type: Grant
    Filed: November 26, 1997
    Date of Patent: July 27, 1999
    Assignee: Pharmacon Forschung und Beratung GmbH
    Inventors: Christian Noe, Antje Weigand-Becker